HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q3 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,301,101 | +3.7% | 639,664 | -1.5% | 0.01% | 0.0% |
| Q2 2023 | $55,267,609 | +3.0% | 649,138 | +0.1% | 0.01% | 0.0% |
| Q1 2023 | $53,658,989 | +5.6% | 648,447 | +0.4% | 0.01% | 0.0% |
| Q4 2022 | $50,814,193 | +5.5% | 646,080 | -0.7% | 0.01% | 0.0% |
| Q3 2022 | $48,167,000 | +11.6% | 650,656 | -1.7% | 0.01% | +22.2% |
| Q2 2022 | $43,161,000 | +0.6% | 662,180 | -2.4% | 0.01% | +12.5% |
| Q1 2022 | $42,888,000 | +14.4% | 678,382 | -4.1% | 0.01% | +33.3% |
| Q4 2021 | $37,502,000 | -25.5% | 707,056 | -0.9% | 0.01% | -33.3% |
| Q3 2021 | $50,353,000 | +6.0% | 713,306 | +0.1% | 0.01% | +12.5% |
| Q2 2021 | $47,483,000 | -2.4% | 712,532 | +62.6% | 0.01% | -11.1% |
| Q1 2021 | $48,646,000 | +0.7% | 438,210 | +7.7% | 0.01% | 0.0% |
| Q4 2020 | $48,294,000 | +35.1% | 406,692 | -0.8% | 0.01% | +12.5% |
| Q3 2020 | $35,760,000 | -5.8% | 409,851 | -3.3% | 0.01% | -11.1% |
| Q2 2020 | $37,951,000 | -53.9% | 423,746 | -48.7% | 0.01% | -62.5% |
| Q1 2020 | $82,247,000 | -13.4% | 825,278 | -0.2% | 0.02% | +14.3% |
| Q4 2019 | $94,976,000 | -10.6% | 826,600 | -1.9% | 0.02% | -16.0% |
| Q3 2019 | $106,288,000 | +5.7% | 842,611 | +0.8% | 0.02% | +4.2% |
| Q2 2019 | $100,555,000 | +38.3% | 835,587 | +0.5% | 0.02% | +33.3% |
| Q1 2019 | $72,707,000 | -12.2% | 831,129 | +0.5% | 0.02% | -21.7% |
| Q4 2018 | $82,779,000 | -13.7% | 827,376 | -1.2% | 0.02% | 0.0% |
| Q3 2018 | $95,930,000 | +27.4% | 837,242 | -0.3% | 0.02% | +21.1% |
| Q2 2018 | $75,288,000 | +50.4% | 839,525 | +22.7% | 0.02% | +46.2% |
| Q1 2018 | $50,047,000 | +27.3% | 684,071 | +1.1% | 0.01% | +30.0% |
| Q4 2017 | $39,302,000 | +28.4% | 676,699 | -0.8% | 0.01% | +25.0% |
| Q3 2017 | $30,614,000 | +12.6% | 682,270 | -0.9% | 0.01% | 0.0% |
| Q2 2017 | $27,192,000 | +5.9% | 688,580 | +8.8% | 0.01% | +14.3% |
| Q1 2017 | $25,683,000 | +2.0% | 633,069 | +1.1% | 0.01% | -12.5% |
| Q4 2016 | $25,184,000 | -13.7% | 626,448 | -22.3% | 0.01% | -11.1% |
| Q3 2016 | $29,189,000 | +32.4% | 806,118 | +6.0% | 0.01% | +28.6% |
| Q2 2016 | $22,039,000 | -7.1% | 760,202 | +11.1% | 0.01% | -12.5% |
| Q1 2016 | $23,718,000 | +9.5% | 684,297 | +1.8% | 0.01% | +14.3% |
| Q4 2015 | $21,664,000 | +2.5% | 671,967 | +2.7% | 0.01% | 0.0% |
| Q3 2015 | $21,144,000 | -9.4% | 654,245 | +16.0% | 0.01% | 0.0% |
| Q2 2015 | $23,336,000 | -22.5% | 564,205 | -15.8% | 0.01% | -22.2% |
| Q1 2015 | $30,095,000 | +19.7% | 669,966 | -0.3% | 0.01% | +12.5% |
| Q4 2014 | $25,150,000 | +3.4% | 672,110 | -3.5% | 0.01% | 0.0% |
| Q3 2014 | $24,325,000 | +5.7% | 696,583 | +6.8% | 0.01% | +14.3% |
| Q2 2014 | $23,014,000 | -10.3% | 652,319 | -17.2% | 0.01% | -12.5% |
| Q1 2014 | $25,660,000 | -19.7% | 787,365 | +3.9% | 0.01% | -20.0% |
| Q4 2013 | $31,938,000 | +2.7% | 758,081 | -2.8% | 0.01% | -9.1% |
| Q3 2013 | $31,099,000 | -5.9% | 779,813 | -2.4% | 0.01% | -8.3% |
| Q2 2013 | $33,047,000 | – | 799,199 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |